- Home
- CAVA vs MEDP Comparison
CAVA vs MEDP Comparison
Compare CAVA & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAVA
- MEDP
- Stock Information
- Founded
- CAVA 2006
- MEDP 1992
- Country
- CAVA United States
- MEDP United States
- Employees
- CAVA N/A
- MEDP N/A
- Industry
- CAVA Restaurants
- MEDP Biotechnology: Commercial Physical & Biological Resarch
- Sector
- CAVA Consumer Discretionary
- MEDP Health Care
- Exchange
- CAVA Nasdaq
- MEDP Nasdaq
- Market Cap
- CAVA 10.7B
- MEDP 10.5B
- IPO Year
- CAVA 2023
- MEDP 2016
- Fundamental
- Price
- CAVA $94.16
- MEDP $296.52
- Analyst Decision
- CAVA Buy
- MEDP Hold
- Analyst Count
- CAVA 14
- MEDP 10
- Target Price
- CAVA $123.00
- MEDP $343.22
- AVG Volume (30 Days)
- CAVA 2.4M
- MEDP 651.1K
- Earning Date
- CAVA 05-15-2025
- MEDP 04-21-2025
- Dividend Yield
- CAVA N/A
- MEDP N/A
- EPS Growth
- CAVA 423.81
- MEDP 33.36
- EPS
- CAVA 1.10
- MEDP 13.09
- Revenue
- CAVA $963,713,000.00
- MEDP $2,156,580,000.00
- Revenue This Year
- CAVA $25.45
- MEDP $5.36
- Revenue Next Year
- CAVA $21.09
- MEDP $3.60
- P/E Ratio
- CAVA $87.21
- MEDP $23.05
- Revenue Growth
- CAVA 32.25
- MEDP 9.87
- 52 Week Low
- CAVA $70.00
- MEDP $250.05
- 52 Week High
- CAVA $172.43
- MEDP $459.77
- Technical
- Relative Strength Index (RSI)
- CAVA 58.33
- MEDP 48.77
- Support Level
- CAVA $90.75
- MEDP $284.10
- Resistance Level
- CAVA $96.75
- MEDP $304.08
- Average True Range (ATR)
- CAVA 3.24
- MEDP 12.15
- MACD
- CAVA 0.80
- MEDP 1.08
- Stochastic Oscillator
- CAVA 89.45
- MEDP 79.93
About CAVA CAVA Group Inc.
Cava Group Inc owns and operates a chain of restaurants. It is the category-defining Mediterranean fast-casual restaurant brand, bringing together healthful food and bold, satisfying flavors at scale. The company's dips, spreads, and dressings are centrally produced and sold in grocery stores. The company's operations are conducted as two reportable segments: CAVA and Zoes Kitchen. The company generates all of its revenue from the CAVA segment.
About MEDP Medpace Holdings Inc.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the us, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.